<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Subhash S</submitter><funding>Vetenskapsrådet</funding><funding>Swedish Cancer Society</funding><funding>Barncancerfonden</funding><funding>FoU Västra Götalandsregionen</funding><funding>Stiftelsen för Strategisk Forskning</funding><funding>Knut och Alice Wallenbergs Stiftelse</funding><pagination>106</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5062931</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Methyl-CpG-binding domain protein enriched genome-wide sequencing (MBD-Seq) is a robust and powerful method for analyzing methylated CpG-rich regions with complete genome-wide coverage. In chronic lymphocytic leukemia (CLL), the role of CpG methylated regions associated with transcribed long noncoding RNAs (lncRNA) and repetitive genomic elements are poorly understood. Based on MBD-Seq, we characterized the global methylation profile of high CpG-rich regions in different CLL prognostic subgroups based on IGHV mutational status.&lt;h4>Results&lt;/h4>Our study identified 5800 hypermethylated and 12,570 hypomethylated CLL-specific differentially methylated genes (cllDMGs) compared to normal controls. From cllDMGs, 40 % of hypermethylated and 60 % of hypomethylated genes were mapped to noncoding RNAs. In addition, we found that the major repetitive elements such as short interspersed elements (SINE) and long interspersed elements (LINE) have a high percentage of cllDMRs (differentially methylated regions) in IGHV subgroups compared to normal controls. Finally, two novel lncRNAs (hypermethylated &lt;i>CRNDE&lt;/i> and hypomethylated &lt;i>AC012065.7&lt;/i>) were validated in an independent CLL sample cohort (48 samples) compared with 6 normal sorted B cell samples using quantitative pyrosequencing analysis. The methylation levels showed an inverse correlation to gene expression levels analyzed by real-time quantitative PCR. Notably, survival analysis revealed that hypermethylation of &lt;i>CRNDE&lt;/i> and hypomethylation of &lt;i>AC012065.7&lt;/i> correlated with an inferior outcome.&lt;h4>Conclusions&lt;/h4>Thus, our comprehensive methylation analysis by MBD-Seq provided novel hyper and hypomethylated long noncoding RNAs, repetitive elements, along with protein coding genes as potential epigenetic-based CLL-signature genes involved in disease pathogenesis and prognosis.</pubmed_abstract><journal>Clinical epigenetics</journal><pubmed_title>Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL.</pubmed_title><pmcid>PMC5062931</pmcid><funding_grant_id>RB13-0204</funding_grant_id><funding_grant_id>CAN 2013/386</funding_grant_id><funding_grant_id>Dnr KAW 2014.0057</funding_grant_id><funding_grant_id>dnr E 2012/126</funding_grant_id><funding_grant_id>ALFGBG-507731</funding_grant_id><funding_grant_id>PR2014/0147</funding_grant_id><pubmed_authors>Subhash S</pubmed_authors><pubmed_authors>Andersson PO</pubmed_authors><pubmed_authors>Kanduri C</pubmed_authors><pubmed_authors>Kosalai ST</pubmed_authors><pubmed_authors>Kanduri M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL.</name><description>&lt;h4>Background&lt;/h4>Methyl-CpG-binding domain protein enriched genome-wide sequencing (MBD-Seq) is a robust and powerful method for analyzing methylated CpG-rich regions with complete genome-wide coverage. In chronic lymphocytic leukemia (CLL), the role of CpG methylated regions associated with transcribed long noncoding RNAs (lncRNA) and repetitive genomic elements are poorly understood. Based on MBD-Seq, we characterized the global methylation profile of high CpG-rich regions in different CLL prognostic subgroups based on IGHV mutational status.&lt;h4>Results&lt;/h4>Our study identified 5800 hypermethylated and 12,570 hypomethylated CLL-specific differentially methylated genes (cllDMGs) compared to normal controls. From cllDMGs, 40 % of hypermethylated and 60 % of hypomethylated genes were mapped to noncoding RNAs. In addition, we found that the major repetitive elements such as short interspersed elements (SINE) and long interspersed elements (LINE) have a high percentage of cllDMRs (differentially methylated regions) in IGHV subgroups compared to normal controls. Finally, two novel lncRNAs (hypermethylated &lt;i>CRNDE&lt;/i> and hypomethylated &lt;i>AC012065.7&lt;/i>) were validated in an independent CLL sample cohort (48 samples) compared with 6 normal sorted B cell samples using quantitative pyrosequencing analysis. The methylation levels showed an inverse correlation to gene expression levels analyzed by real-time quantitative PCR. Notably, survival analysis revealed that hypermethylation of &lt;i>CRNDE&lt;/i> and hypomethylation of &lt;i>AC012065.7&lt;/i> correlated with an inferior outcome.&lt;h4>Conclusions&lt;/h4>Thus, our comprehensive methylation analysis by MBD-Seq provided novel hyper and hypomethylated long noncoding RNAs, repetitive elements, along with protein coding genes as potential epigenetic-based CLL-signature genes involved in disease pathogenesis and prognosis.</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016</publication><modification>2024-11-12T09:37:22.202Z</modification><creation>2019-06-06T16:29:25Z</creation></dates><accession>S-EPMC5062931</accession><cross_references><pubmed>27777635</pubmed><doi>10.1186/s13148-016-0274-6</doi></cross_references></HashMap>